Veinplicity is coming to Canada

Physeon is pleased to announce the approval of Veinplicity® as a Class II medical device in Canada. We are currently in negotiation with national distributors and are excited to improve venipuncture and cannulation for Canadian patients. With very positive feedback from hospitals in the UK after just one month on the market, we are anticipating the launch in Canada in late 2016/early 2017 and are looking forward to our first evaluations.

For more information, please get in touch with the team at

Veinplicity: Revolutionizing venous access

#DistributioninCanada #ClassIImedicaldevice


The Veinplicity device is CE marked and registered as a Class IIa medical device in the European Union and as a Class II medical device in Canada. We are seeking FDA approval. The device is manufactured within the ISO 13485 standard in the United States.

Featured Posts
Follow Veinplicity